Cargando…

Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines

Gastric cancer (GC) is a significant cancer-related cause of death worldwide. The most used chemotherapeutic regimen in GC is based on platinum drugs such as cisplatin (CDDP). However, CDDP resistance reduces advanced GC survival. In vitro drug-resistant cell model would help in the understanding of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora-Lagos, Barbara, Cartas-Espinel, Irene, Riquelme, Ismael, Parker, Alyssa C., Piccolo, Stephen R., Viscarra, Tamara, Reyes, María Elena, Zanella, Louise, Buchegger, Kurt, Ili, Carmen, Brebi, Priscilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986722/
https://www.ncbi.nlm.nih.gov/pubmed/31990955
http://dx.doi.org/10.1371/journal.pone.0228331
_version_ 1783492014296268800
author Mora-Lagos, Barbara
Cartas-Espinel, Irene
Riquelme, Ismael
Parker, Alyssa C.
Piccolo, Stephen R.
Viscarra, Tamara
Reyes, María Elena
Zanella, Louise
Buchegger, Kurt
Ili, Carmen
Brebi, Priscilla
author_facet Mora-Lagos, Barbara
Cartas-Espinel, Irene
Riquelme, Ismael
Parker, Alyssa C.
Piccolo, Stephen R.
Viscarra, Tamara
Reyes, María Elena
Zanella, Louise
Buchegger, Kurt
Ili, Carmen
Brebi, Priscilla
author_sort Mora-Lagos, Barbara
collection PubMed
description Gastric cancer (GC) is a significant cancer-related cause of death worldwide. The most used chemotherapeutic regimen in GC is based on platinum drugs such as cisplatin (CDDP). However, CDDP resistance reduces advanced GC survival. In vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize new models of CDDP-resistant GC cell lines (AGS R-CDDP and MKN-28 R-CDDP) obtained through a stepwise increasing drug doses method, in order to understand the molecular mechanisms underlying chemoresistance as well as identify new therapeutic targets for the treatment of GC. Cell viability assays, cell death assays and the expression of resistance molecular markers confirmed that AGS R-CDDP and MKN-28 R-CDDP are reliable CDDP-resistant models. RNA-seq and bioinformatics analyses identified a total of 189 DEGs, including 178 up-regulated genes and 11 down-regulated genes, associated mainly to molecular functions involved in CDDP-resistance. DEGs were enriched in 23 metabolic pathways, among which the most enriched was the inflammation mediated by chemokine and cytokine signaling pathway. Finally, the higher mRNA expression of SERPINA1, BTC and CCL5, three up-regulated DEGs associated to CDDP resistance found by RNA-seq analysis was confirmed. In summary, this study showed that AGS R-CDDP and MKN-28 R-CDDP are reliable models of CDDP resistance because resemble many of resistant phenotype in GC, being also useful to assess potential therapeutic targets for the treatment of gastric cancers resistant to CDDP. In addition, we identified several DEGs associated with molecular functions such as binding, catalytic activity, transcription regulator activity and transporter activity, as well as signaling pathways associated with inflammation process, which could be involved in the development of CDDP resistance in GC. Further studies are necessary to clarify the role of inflammatory processes in GC resistant to CDDP and these models could be useful for these purposes.
format Online
Article
Text
id pubmed-6986722
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69867222020-02-19 Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines Mora-Lagos, Barbara Cartas-Espinel, Irene Riquelme, Ismael Parker, Alyssa C. Piccolo, Stephen R. Viscarra, Tamara Reyes, María Elena Zanella, Louise Buchegger, Kurt Ili, Carmen Brebi, Priscilla PLoS One Research Article Gastric cancer (GC) is a significant cancer-related cause of death worldwide. The most used chemotherapeutic regimen in GC is based on platinum drugs such as cisplatin (CDDP). However, CDDP resistance reduces advanced GC survival. In vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize new models of CDDP-resistant GC cell lines (AGS R-CDDP and MKN-28 R-CDDP) obtained through a stepwise increasing drug doses method, in order to understand the molecular mechanisms underlying chemoresistance as well as identify new therapeutic targets for the treatment of GC. Cell viability assays, cell death assays and the expression of resistance molecular markers confirmed that AGS R-CDDP and MKN-28 R-CDDP are reliable CDDP-resistant models. RNA-seq and bioinformatics analyses identified a total of 189 DEGs, including 178 up-regulated genes and 11 down-regulated genes, associated mainly to molecular functions involved in CDDP-resistance. DEGs were enriched in 23 metabolic pathways, among which the most enriched was the inflammation mediated by chemokine and cytokine signaling pathway. Finally, the higher mRNA expression of SERPINA1, BTC and CCL5, three up-regulated DEGs associated to CDDP resistance found by RNA-seq analysis was confirmed. In summary, this study showed that AGS R-CDDP and MKN-28 R-CDDP are reliable models of CDDP resistance because resemble many of resistant phenotype in GC, being also useful to assess potential therapeutic targets for the treatment of gastric cancers resistant to CDDP. In addition, we identified several DEGs associated with molecular functions such as binding, catalytic activity, transcription regulator activity and transporter activity, as well as signaling pathways associated with inflammation process, which could be involved in the development of CDDP resistance in GC. Further studies are necessary to clarify the role of inflammatory processes in GC resistant to CDDP and these models could be useful for these purposes. Public Library of Science 2020-01-28 /pmc/articles/PMC6986722/ /pubmed/31990955 http://dx.doi.org/10.1371/journal.pone.0228331 Text en © 2020 Mora-Lagos et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mora-Lagos, Barbara
Cartas-Espinel, Irene
Riquelme, Ismael
Parker, Alyssa C.
Piccolo, Stephen R.
Viscarra, Tamara
Reyes, María Elena
Zanella, Louise
Buchegger, Kurt
Ili, Carmen
Brebi, Priscilla
Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title_full Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title_fullStr Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title_full_unstemmed Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title_short Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
title_sort functional and transcriptomic characterization of cisplatin-resistant ags and mkn-28 gastric cancer cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986722/
https://www.ncbi.nlm.nih.gov/pubmed/31990955
http://dx.doi.org/10.1371/journal.pone.0228331
work_keys_str_mv AT moralagosbarbara functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT cartasespinelirene functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT riquelmeismael functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT parkeralyssac functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT piccolostephenr functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT viscarratamara functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT reyesmariaelena functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT zanellalouise functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT bucheggerkurt functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT ilicarmen functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines
AT brebipriscilla functionalandtranscriptomiccharacterizationofcisplatinresistantagsandmkn28gastriccancercelllines